952 related articles for article (PubMed ID: 24419495)
21. The relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study.
Homburg R; Ray A; Bhide P; Gudi A; Shah A; Timms P; Grayson K
Hum Reprod; 2013 Apr; 28(4):1077-83. PubMed ID: 23377771
[TBL] [Abstract][Full Text] [Related]
22. Anti-Müllerian hormone dynamics during ovulation induction treatment with recombinant follicle-stimulating hormone in women with polycystic ovary syndrome.
Dąbkowska-Huć A; Lemm M; Sikora J; Witek A; Skałba P
Endokrynol Pol; 2013; 64(3):203-7. PubMed ID: 23873424
[TBL] [Abstract][Full Text] [Related]
23. Ovarian response is associated with anogenital distance in patients undergoing controlled ovarian stimulation for IVF.
Fabregues F; González-Foruria I; Peñarrubia J; Carmona F
Hum Reprod; 2018 Sep; 33(9):1696-1704. PubMed ID: 30016431
[TBL] [Abstract][Full Text] [Related]
24. Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?
Skałba P; Cygal A; Madej P; Dąbkowska-Huć A; Sikora J; Martirosian G; Romanik M; Olszanecka-Glinianowicz M
Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):254-9. PubMed ID: 21752527
[TBL] [Abstract][Full Text] [Related]
25. Clinical value of serum anti-mullerian hormone and inhibin B in prediction of ovarian response in patients with polycystic ovary syndrome.
Zhang F; Liu XL; Rong N; Huang XW
J Huazhong Univ Sci Technolog Med Sci; 2017 Feb; 37(1):70-73. PubMed ID: 28224431
[TBL] [Abstract][Full Text] [Related]
26. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
[TBL] [Abstract][Full Text] [Related]
27. The follicular output rate in normo-ovulating women undergoing ovarian stimulation is increased after unilateral oophorectomy.
Grynberg M; Pytel S; Peigne M; Sonigo C
Hum Reprod; 2023 Jun; 38(6):1162-1167. PubMed ID: 36961937
[TBL] [Abstract][Full Text] [Related]
28. Gonadotrophin stimulation for in vitro fertilization significantly alters the hormone milieu in follicular fluid: a comparative study between natural cycle IVF and conventional IVF.
von Wolff M; Kollmann Z; Flück CE; Stute P; Marti U; Weiss B; Bersinger NA
Hum Reprod; 2014 May; 29(5):1049-57. PubMed ID: 24608520
[TBL] [Abstract][Full Text] [Related]
29. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
[TBL] [Abstract][Full Text] [Related]
30. Changes in serum markers of patients with PCOS during consecutive clomiphene stimulation cycles: a retrospective study.
Hager M; Hörath S; Frigo P; Koch M; Marculescu R; Ott J
J Ovarian Res; 2019 Oct; 12(1):91. PubMed ID: 31585548
[TBL] [Abstract][Full Text] [Related]
31. Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology.
Bayrak A; Terbell H; Urwitz-Lane R; Mor E; Stanczyk FZ; Paulson RJ
Fertil Steril; 2007 Apr; 87(4):870-5. PubMed ID: 17224152
[TBL] [Abstract][Full Text] [Related]
32. Insights into ovarian response with a fixed low dose FSH stimulation in an IUI programme: the PRORAILS study.
Rutten A; van Ballegooijen H; Broekmans F; Cohlen B;
Hum Reprod; 2022 Jun; 37(7):1440-1450. PubMed ID: 35460412
[TBL] [Abstract][Full Text] [Related]
33. Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH.
Lan VT; Linh NK; Tuong HM; Wong PC; Howles CM
Reprod Biomed Online; 2013 Oct; 27(4):390-9. PubMed ID: 23953069
[TBL] [Abstract][Full Text] [Related]
34. FSHB -211 G>T is a major genetic modulator of reproductive physiology and health in childbearing age women.
Rull K; Grigorova M; Ehrenberg A; Vaas P; Sekavin A; Nõmmemees D; Adler M; Hanson E; Juhanson P; Laan M
Hum Reprod; 2018 May; 33(5):954-966. PubMed ID: 29617818
[TBL] [Abstract][Full Text] [Related]
35. The relationship between serum anti-Müllerian hormone levels and the follicular arrest for women with polycystic ovary syndrome.
Li J; Li R; Yu H; Zhao S; Yu Y; Qiao J
Syst Biol Reprod Med; 2015 Apr; 61(2):103-9. PubMed ID: 25329139
[TBL] [Abstract][Full Text] [Related]
36. The influence of circulating anti-Müllerian hormone on ovarian responsiveness to ovulation induction with gonadotrophins in women with polycystic ovarian syndrome: a pilot study.
Amer SA; Mahran A; Abdelmaged A; El-Adawy AR; Eissa MK; Shaw RW
Reprod Biol Endocrinol; 2013 Dec; 11():115. PubMed ID: 24341292
[TBL] [Abstract][Full Text] [Related]
37. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
Elgindy EA; El-Haieg DO; El-Sebaey A
Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
[TBL] [Abstract][Full Text] [Related]
38. Is assessment of anti-Müllerian hormone and/or antral follicle count useful in the prediction of ovarian response in expected normal responders treated with a fixed dose of recombinant FSH and GnRH antagonists? A prospective observational study.
Ganidou MA; Kolibianakis EM; Venetis CA; Gerou S; Makedos GA; Klearchou N; Tarlatzis BC
Gynecol Endocrinol; 2014 Nov; 30(11):817-21. PubMed ID: 24989633
[TBL] [Abstract][Full Text] [Related]
39. [Effect of luteinizing hormone vs follicular stimulating hormone ratio on anti-Müllerian hormone secretion and folliculogenesis in patients with polycystic ovarian syndrome].
Li Y; Wei LN; Xiong YL; Liang XY
Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):567-70. PubMed ID: 21029609
[TBL] [Abstract][Full Text] [Related]
40. Functional ovarian reserve in transgender men receiving testosterone therapy: evidence for preserved anti-Müllerian hormone and antral follicle count under prolonged treatment.
Yaish I; Tordjman K; Amir H; Malinger G; Salemnick Y; Shefer G; Serebro M; Azem F; Golani N; Sofer Y; Stern N; Greenman Y
Hum Reprod; 2021 Sep; 36(10):2753-2760. PubMed ID: 34411251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
